TP53 and cancer: Some of these p53-responsive lncRNAs have been studied mechanistically, and these may provide attractive therapeutic targets to regulate p53 activity in various cancers, particularly those that still maintain wild-type p53 such as HPV-positive cancers (Figure 4).